Complications with the implant used to treat blood vessel dissection after balloon angioplasty or stent placement can result ...
1d
Medical Device Network on MSNPhilips pulls endovascular implant from market after FDA Class I recall tagPhilips has recommended that customers immediately stop using affected Tack endovascular systems and return unused product to ...
Philips stopped selling its Tack endovascular system because of cases where additional interventions were needed to remove ...
The FDA says user challenges and need for additional procedures drove recommendations to stop using the system immediately.
This recall involves removing devices from use and sale. According to the FDA notice, the device may cause serious injury of ...
Medical device recalls surged last year, driven by stricter FDA oversight and a big jump in the most serious type of recalls.
Philips is pulling from the market an implant designed to help repair the interior of damaged blood vessels, following a serious product recall. | Philips is pulling from the market an implant ...
The U.S. Food & Drug Administration said that Philips has removed and discontinued distribution of Tack Endovascular System ...
An online reviewer is warning about a CPAP machine recall. He claims The Philips Dreamstation CPAP device, recalled in 2023, is still being used and could pose a cancer risk to users. Uncle Nicko ...
With its recent clearance in France, the Sleep & Respiratory Care business at Philips can once again sell products in all ...
Philips has posted 33.6% higher losses for 2024 compared to 2023 as the company continues to battle weaker demand in China and settlements for its faulty sleep apnoea devices. Philips reported ...
Full Year and Q4 Group performance highlights Sales of EUR 18.0 billion in 2024, comparable sales growth 1%; EUR 5.0 billion in Q4, comparable sales growth 1%, despite double-digit decline in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results